Serological response to treatment of syphilis according to disease stage and HIV status

Clinical Infectious Diseases

Volumn 55, Issue 12, 2012, Pages 1615-1622

  Knaute, Damaris Fröhlich ^a   Graf, Nicole ^b   Lautenschlager, Stephan ^c   Weber, Rainer ^b   Bosshard, Philipp P ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c TRIEMLI HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REINFECTION; RETROSPECTIVE STUDY; SEROLOGY; SYPHILIS; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; ANTIBODIES, BACTERIAL; ANTITREPONEMAL AGENTS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOGLOBULIN M; MALE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SEROLOGIC TESTS; SYPHILIS; TREATMENT OUTCOME;

EID: 84870222937     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis757     Document Type: Article

References (29)

1. Hook EW, Peeling RW. Syphilis control-A continuing challenge. N Engl J Med 2004; 351:122-4.
2. Fenton KA, Lowndes CM. Recent trends in the epidemiology of sexually transmitted infections in the European Union. Sex Transm Infect 2004; 80:255-63.
3. Sexually transmitted disease surveillance, 2009. Available at: Http://www.cdc.gov/std/stats09/toc.htm. Accessed 27 June 2011.
4. Rolfs RT, Joesoef MR, Hendershot EF, et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. N Engl J Med 1997; 337:307-14.
5. Manavi K, McMillan A. The outcome of treatment of early latent syphilis and syphilis with undetermined duration in HIV-infected and HIV-uninfected patients. Int J STD AIDS 2007; 18:814-8. (Pubitemid 351738858)
6. Lynn WA, Lightman S. Syphilis and HIV: A dangerous combination. Lancet Infect Dis 2004; 4:456-66.
7. Singh AE, Romanowski B. Syphilis: Review with emphasis on clinical, epidemiologic, and some biologic features. Clin Microbiol Rev 1999; 12:187-209.
8. Thurnheer MC, Weber R, Toutous-Trellu L, et al. Occurrence, risk factors, diagnosis and treatment of syphilis in the prospective observational Swiss HIV Cohort Study. AIDS 2010; 24:1907-16.
9. Creegan L, Bauer HM, Samuel MC, Klausner J, Liska S, Bolan G. An evaluation of the relative sensitivities of the venereal disease research laboratory test and the Treponema pallidum particle agglutination test among patients diagnosed with primary syphilis. Sex Transm Dis 2007; 34:1016-8. (Pubitemid 350158855)
10. Janier M, Chastang C, Spindler E, et al. A prospective study of the influence of HIV status on the seroreversion of serological tests for syphilis. Dermatology 1999; 198:362-9. (Pubitemid 29335729)
11. Larsen SA, Steiner BM, Rudolph AH. Laboratory diagnosis and interpretation of tests for syphilis. Clin Microbiol Rev 1995; 8:1-21.
12. Tramont EC. Treponema pallidum (syphilis). In: Mandell GL, Bennett JEDolin R, eds. Principles and practice of infectious diseases. 6th ed. Vol 2. Philadelphia: Elsevier, 2005:2768-85.
13. Sena AC, White BL, Sparling PF. Novel Treponema pallidum serologic tests: A paradigm shift in syphilis screening for the 21st century. Clin Infect Dis 2010; 51:700-8.
14. French P, Gomberg M, Janier M, Schmidt B, van Voorst Vader P, Young H. IUSTI: 2008 European guidelines on the management of syphilis. Int J STD AIDS 2009; 20:300-9.
15. Goeman J, Kivuvu M, Nzila N, et al. Similar serological response to conventional therapy for syphilis among HIV-positive and HIV-negative women. Genitourin Med 1995; 71:275-9.
16. Long CM, Klausner JD, Leon S, et al. Syphilis treatment and HIV infection in a population-based study of persons at high risk for sexually transmitted disease/HIV infection in Lima, Peru. Sex Transm Dis 2006; 33:151-5. (Pubitemid 43790823)
17. Riedner G, Rusizoka M, Todd J, et al. Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. N Engl J Med 2005; 353:1236-44.
18. Farhi D, Benhaddou N, Grange P, et al. Clinical and serologic baseline and follow-up features of syphilis according to HIV status in the post-HAART era. Medicine 2009; 88:331-40.
19. Gourevitch MN, Selwyn PA, Davenny K, et al. Effects of HIV infection on the serologic manifestations and response to treatment of syphilis in intravenous drug users. Ann Intern Med 1993; 118:350-5. (Pubitemid 23070619)
20. Hutchinson CM, Hook EW 3rd, Shepherd M, Verley J, Rompalo AM. Altered clinical presentation of early syphilis in patients with human immunodeficiency virus infection. Ann Intern Med 1994; 121:94-100.
21. Kingston MA, Higgins SP. Comparison of the serological response to treatment of early syphilis in HIV positive versus HIV negative individuals. Sex Transm Infect 2004; 80:152-3. (Pubitemid 38496846)
22. Ghanem KG, Erbelding EJ, Wiener ZS, Rompalo AM. Serological response to syphilis treatment in HIV-positive and HIV-negative patients attending sexually transmitted diseases clinics. Sex Transm Infect 2007; 83:97-101.
23. Gonzalez-Lopez JJ, Guerrero ML, Lujan R, Tostado SF, de Gorgolas MRequena L. Factors determining serologic response to treatment in patients with syphilis. Clin Infect Dis 2009; 49:1505-11.
24. Telzak EE, Greenberg MS, Harrison J, Stoneburner RL, Schultz S. Syphilis treatment response in HIV-infected individuals. AIDS 1991; 5:591-5.
25. Yinnon AM, Coury-Doniger P, Polito R, Reichman RC. Serologic response to treatment of syphilis in patients with HIV infection. Arch Intern Med 1996; 156:321-5. (Pubitemid 26058484)
26. Romanowski B, Sutherland R, Fick GH, Mooney D, Love EJ. Serologic response to treatment of infectious syphilis. Ann Intern Med 1991; 114:1005-9.
27. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010; 59:1-110.
28. McMillan A, Young H. Reactivity in the Venereal Diseases Research Laboratory test and the Mercia IgM enzyme immunoassay after treatment of early syphilis. Int J STD AIDS 2008; 19:689-93.
29. Rotty J, Anderson D, Garcia M, et al. Preliminary assessment of Treponema pallidum-specific IgM antibody detection and a new rapid point-of-care assay for the diagnosis of syphilis in human immunodeficiency virus-1-infected patients. Int J STD AIDS 2010; 21:758-64.